142 related articles for article (PubMed ID: 24032414)
1. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.
Hashem FM; Nasr M; Khairy A
Pharm Dev Technol; 2014 Nov; 19(7):824-32. PubMed ID: 24032414
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation.
Reddy LH; Vivek K; Bakshi N; Murthy RS
Pharm Dev Technol; 2006; 11(2):167-77. PubMed ID: 16749527
[TBL] [Abstract][Full Text] [Related]
3. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
[TBL] [Abstract][Full Text] [Related]
4. Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.
Kapse SV; Gaikwad RV; Samad A; Devarajan PV
Int J Pharm; 2012 Jun; 429(1-2):104-12. PubMed ID: 22414426
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
8. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.
Jain AK; Swarnakar NK; Godugu C; Singh RP; Jain S
Biomaterials; 2011 Jan; 32(2):503-15. PubMed ID: 20934747
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
[TBL] [Abstract][Full Text] [Related]
10. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
Jain AK; Thanki K; Jain S
Mol Pharm; 2013 Sep; 10(9):3459-74. PubMed ID: 23927416
[TBL] [Abstract][Full Text] [Related]
11. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes.
Shaker DS; Shaker MA; Hanafy MS
Int J Pharm; 2015 Sep; 493(1-2):285-94. PubMed ID: 26200748
[TBL] [Abstract][Full Text] [Related]
13. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
14. Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles.
Jain S; Heeralal B; Swami R; Swarnakar NK; Kushwah V
AAPS PharmSciTech; 2018 Jan; 19(1):460-469. PubMed ID: 28785860
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats.
Dwivedi P; Khatik R; Khandelwal K; Taneja I; Raju KS; Wahajuddin ; Paliwal SK; Dwivedi AK; Mishra PR
Int J Pharm; 2014 May; 466(1-2):321-7. PubMed ID: 24657144
[TBL] [Abstract][Full Text] [Related]
16. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
Shete H; Chatterjee S; De A; Patravale V
Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
18. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
19. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.
Dong Z; Guo J; Xing X; Zhang X; Du Y; Lu Q
Biomed Pharmacother; 2017 May; 89():297-304. PubMed ID: 28236703
[TBL] [Abstract][Full Text] [Related]
20. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]